← Oncology Approval Tracker

FDA DECISION ·

Retevmo

selpercatinib · Eli Lilly

Traditional approvalTraditional conversionNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with metastatic RET fusion-positive NSCLC identified by an FDA-approved test.

LAMPGEN ANALYSIS

Why it matters

This confirms the lung-specific accelerated indication via traditional approval.

What research teams should watch

Distinguish this conversion from the separate same-day tumor-agnostic accelerated approval.

PRIMARY RECORDS

Sources